Eric Singhi/faculty.mdanderson.org
Aug 3, 2025, 12:31
Eric Singhi: Long Term Safety Follow-Up with RET Inhibitors
Eric Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, shared a post on X:
“Dr. Luis Raez, chair of Best of ASCO Miami, delivers an excellent presentation focused on updates in RET, NTRK, and NRG1.
Loved hearing about long term safety follow up with RET inhibitors. Clearly, biomarker testing is so important in NSCLC!”
More posts featuring Eric Singhi on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 25, 2025, 20:58
Aug 25, 2025, 20:44
Aug 25, 2025, 20:33
Aug 25, 2025, 19:54
Aug 25, 2025, 19:00
Aug 25, 2025, 17:36